Green Thumb Industries reported Q2 2026 revenue of $306.7 million, up 4.6% year-over-year, driven by retail growth in Minnesota and other states despite pricing pressures. The company achieved a GAAP net income of $4.9 million and normalized EBITDA of $84.3 million, supported by strong brand performance and strategic share repurchases. Key developments include Virginia's upcoming adult-use cannabis sales and expansion in New Jersey and Pennsylvania. Green Thumb remains optimistic about market opportunities and regulatory changes benefiting its scale and product portfolio.
Avalanche (AVAX) has surged past the $10 mark after breaking out from a consolidation range between $7.00 and $8.20, supported by a sharp increase in trading volume. The price climbed to around $10.27, clearing multiple resistance levels and reclaimi...
Zcash (ZEC) price retreated from a recent high near $1,600 to around $1,443 amid increased selling pressure, signaling a healthy correction after a strong rally. Despite the pullback, technical indicators remain bullish, with ZEC holding above major ...
Avalanche's AVAX price rose 18% due to three key events: New York Life Investment Management launched its first tokenized high-yield bond fund on Avalanche, Paxos added AVAX to its regulated payment services, and a network upgrade on September 22 wil...
Orthocell Ltd has made its first commercial sales of Remplir, a nerve repair product, in Thailand following Thai FDA approval and the appointment of MediTime as its exclusive distributor. This launch opens access to Thailand's estimated $84 million n...
Strategy (MSTR) stock surged 16.39%, closing at $153.92 after heavy trading volume more than doubling its average daily shares. The rise is closely tied to Bitcoin's price, as Strategy holds around 845,000 BTC worth about $69 billion, making Bitcoin'...
